LifeMD director receives 85,000 share-based awards
Simon Roberto reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Simon Roberto reported acquisition or exercise transactions in this Form 4 filing.
LifeMD, Inc. reported that director Simon Roberto received two equity awards of common stock. On May 4, 2026, he was granted 50,000 restricted shares that vested immediately. On August 11, 2026, he received 35,000 restricted stock units that are scheduled to vest on June 1, 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F2 | 35,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 50,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. The grant of restricted shares vests immediately.
- F2. Restricted stock units that vest on June 1, 2027.
Key Figures
Key Terms
Restricted stock units financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did LifeMD (LFMD) disclose for Simon Roberto?
What are the vesting terms of Simon Roberto’s August 11, 2026 LifeMD (LFMD) award?
Were Simon Roberto’s LifeMD (LFMD) equity awards purchases or grants?
Does the Form 4 indicate any sales of LifeMD (LFMD) stock by Simon Roberto?
AI-generated analysis. How Rhea-AI works. Not financial advice.